Popular Antidepressants: How They Stack Up

To rate the 12 antidepressants studied, researchers used two separate measures. The first was efficacy -- or how likely patients were to experience the desired effects of the drug. The second was acceptability -- the likelihood that a patient would continue using a drug for the duration of the study (it is generally assumed that a high ratio of patients dropping out indicates the presence of undesirable side effects for a drug).


1) Mirtazapine (Remeron)

2) Escitalopram (Lexapro)

3) Venlafaxine (Effexor)

4) Sertraline (Zoloft)

5) Citalopram (Celexa)

6) Buproprion (Wellbutrin)

7) Paroxetine (Paxil)

8) Milnacipran (Savella)

9) Fluoxetine (Prozac)

10) Duloxetine (Cymbalta)

11) Fluvoxamine (Luvox)

12) Reboxetine (Vestra)


1) Sertraline (Zoloft)

2) Escitalopram (Lexapro)

3) Buproprion (Wellbutrin)

4) Citalopram (Celexa)

5) Fluoxetine (Prozac)

6) Milnacipran (Savella)

7) Mirtazapine (Remeron)

8) Venlafaxine (Effexor)

9) Paroxetine (Paxil)

10) Duloxetine (Cymbalta)

11) Fluvoxamine (Luvox)

12) Reboxetine (Vestra)

Source: Cipriani et al, "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis." Lancet (2009).

Join the Discussion
You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.
blog comments powered by Disqus
You Might Also Like...
See It, Share It
PHOTO: Left, Sabrina Allen, 4, is shown in this photo provided by the National Center for Missing and Exploited Children; right, Sabrina Allen, 17, is seen in this undated handout photo.
National Center for Missing and Exploited Children|Courtesy of PI Phillip Klein
Kelly Ripa
Seth Poppel/Yearbook Library
PHOTO: A long-distance bus station is filled with passengers at the start of Golden Week on Oct. 1, 2014 in Zhengzhou, China.
ChinaFotoPress/ChinaFotoPress via Getty Images